Evan Dellon, MD, MPH

University of North Carolina School of Medicine
Chapel Hill, North Carolina

Disclosure information not submitted.

Presentation(s):

• D0207 - Clinical Features and Treatment Response to Topical Steroids in Ethnic and Racial Minority Patients With Eosinophilic Esophagitis

  Tuesday, October 25, 2022
  10:00 AM – 12:00 PM ET

• D0203 - Diagnostic Delay and Misdiagnosis of Non-Esophageal Eosinophilic Gastrointestinal Diseases

  Tuesday, October 25, 2022
  10:00 AM – 12:00 PM ET

• D0204 - Effect of Proton Pump Inhibitor Treatment in “PPI Non-Responsive” Patients With Eosinophilic Esophagitis

  Tuesday, October 25, 2022
  10:00 AM – 12:00 PM ET

• D0206 - High Burden of Disease and Associated Costs for Eosinophilic Gastrointestinal Diseases: Results From an Online Patient-Centered Research Network

  Tuesday, October 25, 2022
  10:00 AM – 12:00 PM ET

• D0202 - Lirentelimab (AK002) Safety and Efficacy in Patients With Higher Eosinophil Thresholds: Supplementary Analysis of Phase 2/3 EoE KRYPTOS Trial

  Tuesday, October 25, 2022
  10:00 AM – 12:00 PM ET

• D0201 - Results from KRYPTOS, a Phase 2/3 Study of Lirentelimab (AK002) in Adults and Adolescents With EoE

  Tuesday, October 25, 2022
  10:00 AM – 12:00 PM ET

• D0205 - The Eosinophilic Esophagitis Patient With Multiple Atopic Conditions: Clinical Characteristics and Treatment Response to Topical Steroids

  Tuesday, October 25, 2022
  10:00 AM – 12:00 PM ET